Martingale Asset Management L P Has $14.84 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Martingale Asset Management L P decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 17.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 49,453 shares of the company's stock after selling 10,305 shares during the quarter. Martingale Asset Management L P's holdings in HCA Healthcare were worth $14,843,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $31,000. Tidemark LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth approximately $36,000. Activest Wealth Management boosted its stake in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after purchasing an additional 125 shares during the period. Pinnacle Bancorp Inc. raised its stake in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after purchasing an additional 50 shares during the period. Finally, Eastern Bank purchased a new position in shares of HCA Healthcare during the fourth quarter valued at $62,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

HCA traded up $3.11 during midday trading on Monday, reaching $336.48. The company's stock had a trading volume of 275,942 shares, compared to its average volume of 1,386,736. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The stock has a market cap of $82.84 billion, a P/E ratio of 15.32, a PEG ratio of 1.10 and a beta of 1.48. The company has a fifty day simple moving average of $327.53 and a 200 day simple moving average of $336.07. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the company posted $5.90 earnings per share. Research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were given a $0.72 dividend. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.86%. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare's dividend payout ratio (DPR) is 13.11%.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.30% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on HCA shares. Barclays dropped their target price on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. Bank of America decreased their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 27th. Truist Financial reduced their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.